Madrigal Pharmaceuticals's total assets for Q4 2025 were $1.26B, a decrease of -7.55% from the previous quarter. MDGL total liabilities were $656.90M for the fiscal quarter, a -10.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.